RxDoctor Payments Data

Taylor Tapscott, NP

Nurse Practitioner · Knoxville, TNNPI 1174028336

Payments from drug & device makers

$5,023in general payments, 2019–2025

Across 107 payments — averaging $46.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Alpha Orthopedic Systems$1K
  • Amgen$799
  • Radius Health, Inc.$454
  • Johnson & Johnson$185
  • C. R. Bard, Inc. & Subsidiaries$146
  • plus $515 from 11 others

What the payments were for

  • Travel & lodging$90818%
  • Food & beverage$2,71254%
  • Education$1,40328%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,023 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$96,507
Medicare patients
368
Services billed
2,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide36$116,900
Evenity (2 Syringes)Romosozumab-Aqqg31$74,088
ProliaDenosumab22$37,413
EliquisApixaban12$6,911
Celecoxib85$1,721
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen105$750
Methocarbamol82$738
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$601
Meloxicam55$260
Tizanidine Hcl20$225
Diclofenac Sodium13$222
Gabapentin41$160
Tramadol Hcl47$126
Cyclobenzaprine Hcl12$94
Amoxicillin36$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$454$116,90036 claims
AmgenEvenity (2 Syringes), Prolia$799$111,50153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →